23 January 2018
   
Museveni hails Trump for shithole slur
ZRP ‘Idiot’ Charamba loses cop insult case
Gukurahundi: Blame govt, not me – says ED
SA: Jazz legend Hugh Masekela dies
Cholera: Angry minister blasts city councils
Mzembi challenges arrest; quits politics
Mudzuri: Amnesty for MDC-T cop murder 3
Mnangagwa: Grace mentally unstable
MORE NEWS
Govt reduces excise duty on fuel
Filthy 5-Star hotels: Economy blamed
MORE BUSINESS
‘Am I African’ explores Zim's race conflict
Gafa’s Epworth concert draws thousands
MORE SHOWBIZ
Billiat might still leave: Sundowns coach
Katsande: Chiefs show championship mentality
MORE SPORTS
Mnangagwa’s ‘New’ Zim merits support
Zhuwao: kleptocracy and EDiots in Davos
MORE OPINION
 
Mnangagwa off to Davos empty handed
Economy: the need for a paradigm shift
MORE COLUMNISTS
 
 

Datlabs says new product now generates 60pct of revenue

29/08/2016 00:00:00
by Source.co.zw
 
 
RELATED STORIES

HARARE: Local pharmaceutical and personal care products manufacturer Datlabs Limited says its new product camphor product now contributes 60 percent of its revenue on the back of increased demand, helped by a government ban on imports.

Johannesburg Stock Exchange-listed Tiger Brands in 2013 terminated a 50-year manufacturing arrangement with Datlabs to produce its Ingrams Camphor Cream locally under license. The move prompted Datlabs to launch its own rival Camphacare product.

“Ingrams Camphor used to contribute over 60 percent of our revenue but we have seen increased uptake and confidence in our local product and Camphacare now contributes 60 percent to our revenue,” the product manager Lobengula Dube told The Source at the Harare Agriculture Show.

Datlabs is now eying the export market, he added.

Dube said Datlabs’ capacity utilization had doubled to 80 percent since 2014, producing 500,000 jars of Camphacare every month.

The local market is worth $10 million annually, Dube added.

Datlabs also produces leading brands such as Cafemol, Panado, Solphyllex and Lanolene Milk.



Advertisement


 
Email this to a friend Printable Version Discuss This Story
Share this article:

Digg it

Del.icio.us

Reddit

Newsvine

Nowpublic

Stumbleupon

Face Book

Myspace

Fark

 
 
 
comments powered by Disqus
 
RSS NewsTicker